Daiichi Sankyo to pay $39M to settle DOJ claims it paid kickbacks to docs

Japanese drugmaker Daiichi Sankyo will pay $39 million to state and federal health programs, and a whistleblower, to settle claims it paid doctors kickbacks to prescribe some of its drugs, Reuters reports. The settlement, the Justice Department said, stemmed from a whistleblower lawsuit filed by former Daiichi sales representative Kathy Fragoules. She will get $6.1 million of the settlement. The drugmaker was accused of enticing doctors with speaking fees and lavish dinners, sometimes to speak only to their own staffs, the government contended. Story

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.